Thermo Fisher Scientific Inc
TMO572.280USD
-6.720-1.16%
Fechamento 12/12, 16:00（ET）Cotações atrasadas em 15 min
215.01BValor de mercado
33.02P/L TTM
Mais detalhes de Thermo Fisher Scientific Inc Empresa
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Informações de Thermo Fisher Scientific Inc
Código da empresaTMO
Nome da EmpresaThermo Fisher Scientific Inc
Data de listagemAug 27, 1980
CEOCasper (Marc N)
Número de funcionários125000
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 27
Endereço168 Third Avenue
CidadeWALTHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02451
Telefone17816221000
Sitehttps://corporate.thermofisher.com/us/en/index.html
Código da empresaTMO
Data de listagemAug 27, 1980
CEOCasper (Marc N)
Executivos da empresa Thermo Fisher Scientific Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
11.48K
--
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.66K
-20.84%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.62K
+7.01%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Por RegiãoUSD
Nome
Receita
Proporção
North America
5.72B
52.71%
Europe
2.83B
26.07%
Asia Pacific
1.92B
17.69%
Other Regions
383.00M
3.53%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Distribuição de ações
Atualizado em: dom, 16 de nov
Atualizado em: dom, 16 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
Outro
77.22%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
Outro
77.22%
Tipos de investidores
Investidores
Proporção
Investment Advisor
50.57%
Investment Advisor/Hedge Fund
30.17%
Pension Fund
2.80%
Bank and Trust
2.73%
Research Firm
2.62%
Hedge Fund
1.91%
Sovereign Wealth Fund
1.86%
Family Office
0.20%
Family Office
0.20%
Outro
6.92%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
4341
344.96M
91.81%
-9.54M
2025Q2
4335
351.93M
93.19%
-4.42M
2025Q1
4395
350.27M
92.78%
-5.82M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
33.62M
8.9%
+304.63K
+0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.94M
4.49%
-335.33K
-1.94%
Jun 30, 2025
State Street Investment Management (US)
16.48M
4.36%
-58.52K
-0.35%
Jun 30, 2025
Capital World Investors
9.58M
2.54%
-1.48M
-13.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
8.11M
2.15%
-12.40K
-0.15%
Jun 30, 2025
Fidelity Management & Research Company LLC
3.22M
0.85%
-727.96K
-18.43%
Jun 30, 2025
T. Rowe Price Associates, Inc.
5.00M
1.32%
-3.74M
-42.82%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
5.61M
1.49%
+1.13M
+25.29%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.59M
1.48%
-469.24K
-7.75%
Jun 30, 2025
Putnam Investment Management, L.L.C.
3.35M
0.89%
+55.55K
+1.69%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
VanEck Morningstar Wide Moat Value ETF
5.72%
Goldman Sachs Future Health Care Equity ETF
5.09%
Honeytree US Equity ETF
4.9%
Parnassus Value Select ETF
4.52%
Health Care Select Sector SPDR Fund
4.39%
Proshares Ultra Health Care
4.24%
iShares U.S. Healthcare ETF
4.2%
AdvisorShares Focused Equity ETF
4.01%
GMO US Quality ETF
4%
Brookstone Value Stock ETF
3.97%
Ver Mais
VanEck Morningstar Wide Moat Value ETF
Proporção5.72%
Goldman Sachs Future Health Care Equity ETF
Proporção5.09%
Honeytree US Equity ETF
Proporção4.9%
Parnassus Value Select ETF
Proporção4.52%
Health Care Select Sector SPDR Fund
Proporção4.39%
Proshares Ultra Health Care
Proporção4.24%
iShares U.S. Healthcare ETF
Proporção4.2%
AdvisorShares Focused Equity ETF
Proporção4.01%
GMO US Quality ETF
Proporção4%
Brookstone Value Stock ETF
Proporção3.97%
Dividendo
Um total de
2.29B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jul 10, 2025
TMO.NB Final Cash Dividend of gross USD 0.43 paid on Oct 15, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 15, 2025
Sep 15, 2025
May 21, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Jul 15, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 15, 2025
Jun 13, 2025
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de Thermo Fisher Scientific Inc?
Os cinco principais acionistas de Thermo Fisher Scientific Inc são:
The Vanguard Group, Inc. detém 33.62M Ações, representando 8.90% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 16.94M Ações, representando 4.49% do total de Ações.
State Street Investment Management (US) detém 16.48M Ações, representando 4.36% do total de Ações.
Capital World Investors detém 9.58M Ações, representando 2.54% do total de Ações.
Geode Capital Management, L.L.C. detém 8.11M Ações, representando 2.15% do total de Ações.
The Vanguard Group, Inc. detém 33.62M Ações, representando 8.90% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 16.94M Ações, representando 4.49% do total de Ações.
State Street Investment Management (US) detém 16.48M Ações, representando 4.36% do total de Ações.
Capital World Investors detém 9.58M Ações, representando 2.54% do total de Ações.
Geode Capital Management, L.L.C. detém 8.11M Ações, representando 2.15% do total de Ações.
Quais são os três principais tipos de acionistas de Thermo Fisher Scientific Inc?
Os três principais tipos de acionistas da Thermo Fisher Scientific Inc são:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Quantas instituições possuem ações da Thermo Fisher Scientific Inc (TMO)?
Em 2025Q3, 4341 instituições possuíam ações da Thermo Fisher Scientific Inc, com valor de mercado aproximado de 344.96M, representando 91.81% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em -1.39%.
Qual é a maior fonte de receita da Thermo Fisher Scientific Inc?
Em FY2025Q2, o segmento de negócios Consumables gerou a maior receita para Thermo Fisher Scientific Inc, totalizando 4.61B e representando 42.43% da receita total.
